PHVS
Pharvaris NV

904
Mkt Cap
$1.8B
Volume
163,411.00
52W High
$29.80
52W Low
$11.51
PE Ratio
-8.73
PHVS Fundamentals
Price
$28.10
Prev Close
$28.00
Open
$28.08
50D MA
$26.15
Beta
0.72
Avg. Volume
197,715.40
EPS (Annual)
-$2.69
P/B
4.98
Rev/Employee
$0.00
$745.77
Loading...
Loading...

About

Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Johannes Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
108

Frequently Asked Questions

What is Market Cap of Pharvaris NV?
What is the 52-week high for Pharvaris NV?
What is the 52-week low for Pharvaris NV?
What is Pharvaris NV stock price today?
What was Pharvaris NV stock price yesterday?
What is the PE ratio of Pharvaris NV?
What is the Price-to-Book ratio of Pharvaris NV?
What is the 50-day moving average of Pharvaris NV?
How many employees does Pharvaris NV have?

Latest PHVS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.